Orphina is a pre-startup biotechnology company focused on preserving and prolonging muscle health. Our initial clinical gene therapy program is for orphan disease indications of unmet medical need. Our technology allows re-dosing, while protecting vital organs, thereby increasing therapeutic effect and reducing the risk of severe or life-threatening side effects.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 4774 Park Granada,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.orphina.com
- Keywords
- Biotechnology and Gene therapy.
- HQ
- Calabasas, California
Orphina Biotechnology Questions
Orphina Biotechnology's website is https://www.orphina.com
Orphina Biotechnology's LinkedIn profile is https://www.linkedin.com/company/orphina
Orphina Biotechnology has
2 employees.
View email and phone details for 2
employees at Orphina Biotechnology.
Orphina Biotechnology's industry is
Biotechnology Research
Orphina Biotechnology's top competitors are
Remd Biotherapeutics Inc.,
Celavie Biosciences,
Dumo Digital Strategies,
Amerstem Inc.,
Oncotherapeutics,
Noahgen,
Sobi - Swedish Orphan Biovitrum Ab (Publ),
Pacific Coast Biologics,
Atara Biotherapeutics,
Askgene Pharma, Inc..
Orphina Biotechnology's categories are Biotechnology Research
Orphina Biotechnology's founding year is 2020
